AM, S., A, A., G, A., K, B., S, B., H, B., . . . AG, R. (2022). Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK. Clinical and experimental immunology, 209(3), 247. https://doi.org/10.1093/cei/uxac008
Chicago Style (17th ed.) CitationAM, Shields, et al. "Outcomes Following SARS-CoV-2 Infection in Patients with Primary and Secondary Immunodeficiency in the UK." Clinical and Experimental Immunology 209, no. 3 (2022): 247. https://doi.org/10.1093/cei/uxac008.
MLA (9th ed.) CitationAM, Shields, et al. "Outcomes Following SARS-CoV-2 Infection in Patients with Primary and Secondary Immunodeficiency in the UK." Clinical and Experimental Immunology, vol. 209, no. 3, 2022, p. 247, https://doi.org/10.1093/cei/uxac008.